Changing European IVD landscape and economic pressures lead to lower 2009 IVD sales growth
This article was originally published in Clinica
Sales of IVD products in Europe totalled €10.2bn ($13.4bn) in 2009, representing just 0.8% of the region’s total healthcare expenditure (THE), the European Diagnostic Manufacturers Association (EDMA) reports. Furthermore, annual IVD sales growth slowed in 2009 compared to the previous year: revenue increased 3%from 2008 to2009, while it increased just over 4%between 2007 and 2008.
You may also be interested in...
The UK responsible person is the UK equivalent of the Authorized Representative in the EU. MedTech Europe’s Jesús Rueda gives an update on the early experiences of medtech manufacturers seeking to comply with the UK’s new standalone regulations.
The European Commission has reluctantly allowed virtual audits in the context of new MDR and IVDR. The EU notified body association is helping the collective effort to meet its strict requirements.
The new EU MDR rules for economic operators are complex and burdensome for those not used to them. Chad Reynolds of RMQ+ outlines practical strategies for managing economic operators efficiently, and with a view to long-term compliance.